Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine-Reference-Cited by-同舟云学术

Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine

Published:2019-07-03 Issue:1 Volume:101 Page:207-213
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Grant-Klein Rebecca J.¹,Antonello Joseph¹,Nichols Rick²,Dubey Sheri¹,Simon Jakub¹

Affiliation:

1. Merck & Co., Inc., Kenilworth, New Jersey;

2. Crozet BioPharma, Devens, Massachusetts

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference18 articles.

1. Emerging infectious diseases: threats to human health and global stability;Morens;PLoS Pathog,2013

2. Inactivation of Zaire ebolavirus variant Makona in human serum samples analyzed by enzyme-linked immunosorbent assay;Cutts;J Infect Dis,2016

3. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe;Agnandji;N Engl J Med,2016

4. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial;ElSherif;CMAJ,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques;Viruses;2024-07-24

2. The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs;npj Vaccines;2023-06-10

3. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus–Based Filovirus Vaccines in Nonhuman Primates;The Journal of Infectious Diseases;2023-06-08

4. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials;Vaccine;2022-11

5. VSV-based vaccine provides species-specific protection against Sudan virus challenge in macaques;2022-10-27